HCM
ACH

Highbridge Capital Management’s Accendra Health ACH Stock Holding History

Highbridge Capital Management’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-414,700
Closed -$2.41M – 72
2019
Q3 		$2.41M Buy
+414,700
New +$1.86M 0.35% 39

Other funds holding ACH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return

Highbridge Capital Management's ACH Position: Q3 2016 in Review

Highbridge Capital Management sold out of Accendra Health (ACH) in Q3 2016, closing a stake of 6,173 shares — an estimated $230K sold.

Highbridge Capital Management first reported a position in ACH in Q2 2016 and held it in 1 quarter. The position peaked at $230K in Q2 2016. 285 funds tracked by Wall St. Rank hold ACH as of Q3 2016.

  • Highbridge Capital Management reported no remaining Accendra Health position as of Q3 2016 after selling out during the quarter.
  • Highbridge Capital Management sold 6,173 Accendra Health shares in Q3 2016, an estimated $230K.
  • Highbridge Capital Management first reported a position in Accendra Health in Q2 2016 and held it in 1 quarter.
  • Highbridge Capital Management's Accendra Health position peaked at $230K in Q2 2016.
  • 285 funds tracked by Wall St. Rank held Accendra Health as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.